Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Voice of Reflux: Typical Vocal Biomarkers in Patients With Gastroesophageal Reflux Disease

NCT06495606 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT06495606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Voice of Reflux: Typical Vocal Biomarkers in Patients With Gastroesophageal Reflux Disease
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Unknown status
Start date
April 10, 2024
Completion date
August 31, 2025
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd gastroesophageal reflux disease, laryngopharyngeal reflux disease